AD-213
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 27, 2022
A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131
(clinicaltrials.gov)
- P1 | N=43 | Completed | Sponsor: Addpharma Inc. | Active, not recruiting ➔ Completed
Trial completion
November 29, 2021
A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131
(clinicaltrials.gov)
- P1; N=40; Active, not recruiting; Sponsor: Addpharma Inc.; Suspended ➔ Active, not recruiting
Clinical • Enrollment closed
1 to 2
Of
2
Go to page
1